Rules and Regulations. Notification of petition
/register/2021/09/09/2021-19409·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Agency: Food and Drug Administration, HHS
Action: Notification of petition
Citation: FR Doc. 2021-19409 · Docket No. FDA-2021-F-0926 · 21 CFR 172
Summary
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by Monaghan Mushrooms Ireland Unlimited Company, proposing that the food additive regulations be amended to provide for the safe use of vitamin D 2 mushroom powder produced by exposing dried and powdered edible cultivars of Agaricus bisporus to ultraviolet light.
Dates
The food additive petition was filed on June 8, 2021.
Supplementary Information
Under the Federal Food, Drug, and Cosmetic Act (section 409(b)(5) (21 U.S.C. 348(b)(5)), we are giving notice that we have filed a food additive petition (FAP 1A4828), submitted by Monaghan Mushrooms Ireland Unlimited Company, Tullygony, Tyholland, County Monaghan, H18 FW95, Ireland. The petition proposes to amend the food additive regulations in § 172.382 (21 CFR 172.382) Vitamin D 2 mushroom powder to provide for the safe use of vitamin D 2 mushroom powder produced by exposing dried and powdered edible cultivars of Agaricus bisporus to ultraviolet light. The petitioner has claimed that this action is categorically excluded under 21 CFR 25.32(k) because the substance is intended to remain in food through ingestion by consumers and is not intended to replace macronutrients in food. In addition, the petitioner has stated that, to their knowledge, no extraordinary circumstances exist that would warrant at least an environmental assessment (see 21 CFR 25.21). If FDA determines a categorical exclusion applies, neither an environmental assessment nor an environmental impact statement is required. If FDA determines a categorical exclusion does not apply, we will request an environmental assessment and make it available for public inspection. Dated: September 2, 2021. Lauren K. Roth, Acting Principal Associate Commissioner for Policy. [FR Doc. 2021-19409 Filed 9-8-21; 8:45 am]
Connectionstraces to 4
- 21 CFR 172